Annual Current Liabilities
$3.21 M
-$2.31 M-41.89%
September 30, 2024
Summary
- As of February 6, 2025, SONN annual total current liabilities is $3.21 million, with the most recent change of -$2.31 million (-41.89%) on September 30, 2024.
- During the last 3 years, SONN annual current liabilities has fallen by -$3.49 million (-52.11%).
- SONN annual current liabilities is now -60.68% below its all-time high of $8.16 million, reached on September 30, 2022.
Performance
SONN Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$3.21 M
+$100.30 K+3.23%
September 30, 2024
Summary
- As of February 6, 2025, SONN quarterly total current liabilities is $3.21 million, with the most recent change of +$100.30 thousand (+3.23%) on September 30, 2024.
- Over the past year, SONN quarterly current liabilities has increased by +$100.30 thousand (+3.23%).
- SONN quarterly current liabilities is now -82.37% below its all-time high of $18.21 million, reached on March 31, 2020.
Performance
SONN Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
SONN Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -41.9% | +3.2% |
| 3 y3 years | -52.1% | +3.2% |
| 5 y5 years | +11.3% | +3.2% |
SONN Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -60.7% | at low | -61.3% | +20.9% |
| 5 y | 5-year | -60.7% | +11.3% | -82.4% | +20.9% |
| alltime | all time | -60.7% | +11.3% | -82.4% | +20.9% |
Sonnet BioTherapeutics Holdings Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | $3.21 M(-41.9%) | $3.21 M(+3.2%) |
| Jun 2024 | - | $3.11 M(+12.5%) |
| Mar 2024 | - | $2.76 M(+4.2%) |
| Dec 2023 | - | $2.65 M(-52.0%) |
| Sep 2023 | $5.52 M(-32.3%) | $5.52 M(-14.6%) |
| Jun 2023 | - | $6.47 M(-16.8%) |
| Mar 2023 | - | $7.77 M(-6.3%) |
| Dec 2022 | - | $8.29 M(+1.6%) |
| Sep 2022 | $8.16 M | $8.16 M(+25.5%) |
| Jun 2022 | - | $6.50 M(-0.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $6.51 M(+49.9%) |
| Dec 2021 | - | $4.34 M(-35.2%) |
| Sep 2021 | $6.70 M(+41.9%) | $6.70 M(+16.5%) |
| Jun 2021 | - | $5.75 M(+6.6%) |
| Mar 2021 | - | $5.40 M(+2.0%) |
| Dec 2020 | - | $5.29 M(+12.0%) |
| Sep 2020 | $4.72 M(+63.7%) | $4.72 M(+46.3%) |
| Jun 2020 | - | $3.23 M(-82.3%) |
| Mar 2020 | - | $18.21 M |
| Sep 2019 | $2.89 M | - |
FAQ
- What is Sonnet BioTherapeutics Holdings annual total current liabilities?
- What is the all time high annual current liabilities for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings annual current liabilities year-on-year change?
- What is Sonnet BioTherapeutics Holdings quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings quarterly current liabilities year-on-year change?
What is Sonnet BioTherapeutics Holdings annual total current liabilities?
The current annual current liabilities of SONN is $3.21 M
What is the all time high annual current liabilities for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high annual total current liabilities is $8.16 M
What is Sonnet BioTherapeutics Holdings annual current liabilities year-on-year change?
Over the past year, SONN annual total current liabilities has changed by -$2.31 M (-41.89%)
What is Sonnet BioTherapeutics Holdings quarterly total current liabilities?
The current quarterly current liabilities of SONN is $3.21 M
What is the all time high quarterly current liabilities for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high quarterly total current liabilities is $18.21 M
What is Sonnet BioTherapeutics Holdings quarterly current liabilities year-on-year change?
Over the past year, SONN quarterly total current liabilities has changed by +$100.30 K (+3.23%)